Jiangzhong Pharmaceutical Co Ltd (600750) — Capital Reinvestment Ratio
Jiangzhong Pharmaceutical Co Ltd (600750) has a Capital Reinvestment Ratio of 0.29x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥326.81 Million) in capital expenditures (CN¥95.46 Million). Check Jiangzhong Pharmaceutical Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangzhong Pharmaceutical Co Ltd Capital Reinvestment Ratio (2000–2025)
This chart tracks Jiangzhong Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 26 annual periods. For the full cash flow conversion analysis, see 600750 cash flow metrics.
Annual Capital Reinvestment Ratio for Jiangzhong Pharmaceutical Co Ltd (2000–2025)
Year-by-year Capital Reinvestment Ratio for Jiangzhong Pharmaceutical Co Ltd from 2000 to 2025. See Jiangzhong Pharmaceutical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.29x | CN¥970.87 Million | CN¥280.57 Million | ▼ -21.9% |
| 2024 | 0.37x | CN¥786.25 Million | CN¥290.77 Million | ▲ +83.4% |
| 2023 | 0.20x | CN¥1.04 Billion | CN¥208.88 Million | ▼ -40.4% |
| 2022 | 0.34x | CN¥1.02 Billion | CN¥345.64 Million | ▲ +64.6% |
| 2021 | 0.21x | CN¥917.04 Million | CN¥188.49 Million | ▼ -15.3% |
| 2020 | 0.24x | CN¥752.50 Million | CN¥182.53 Million | ▲ +103.8% |
| 2019 | 0.12x | CN¥641.18 Million | CN¥76.33 Million | ▼ -52.3% |
| 2018 | 0.25x | CN¥486.25 Million | CN¥121.38 Million | ▼ -82.8% |
| 2017 | 1.45x | CN¥124.93 Million | CN¥181.21 Million | ▲ +1345.1% |
| 2016 | 0.10x | CN¥698.05 Million | CN¥70.07 Million | ▼ -18.3% |
| 2015 | 0.12x | CN¥510.78 Million | CN¥62.75 Million | ▼ -57.2% |
| 2014 | 0.29x | CN¥356.80 Million | CN¥102.33 Million | ▼ -50.3% |
| 2013 | 0.58x | CN¥111.92 Million | CN¥64.59 Million | ▼ -41.8% |
| 2012 | 0.99x | CN¥226.38 Million | CN¥224.42 Million | ▼ -32.6% |
| 2011 | 1.47x | CN¥168.30 Million | CN¥247.55 Million | ▲ +132.1% |
| 2010 | 0.63x | CN¥222.29 Million | CN¥140.86 Million | ▲ +1138.0% |
| 2009 | 0.05x | CN¥378.32 Million | CN¥19.37 Million | ▼ -32.8% |
| 2008 | 0.08x | CN¥268.87 Million | CN¥20.49 Million | ▲ +4.9% |
| 2007 | 0.07x | CN¥153.63 Million | CN¥11.16 Million | ▼ -86.9% |
| 2006 | 0.56x | CN¥55.24 Million | CN¥30.69 Million | ▲ +68.5% |
| 2005 | 0.33x | CN¥198.45 Million | CN¥65.42 Million | ▼ -96.7% |
| 2004 | 10.01x | CN¥26.28 Million | CN¥263.03 Million | ▲ +241.5% |
| 2003 | 2.93x | CN¥78.98 Million | CN¥231.42 Million | ▲ +141.0% |
| 2002 | 1.22x | CN¥94.90 Million | CN¥115.40 Million | ▲ +892.2% |
| 2001 | 0.12x | CN¥41.28 Million | CN¥5.06 Million | ▼ -45.2% |
| 2000 | 0.22x | CN¥121.77 Million | CN¥27.22 Million | — |